Zheng ZHONG

Management of medical teams, in charge of medical excellence , clinical trial and publication governance &managements, and patient affairs.

In charge of specialty care ,covering Immunology,dermatology ,respiratory,rare diseases and rare blood disorder , which include the new blockbuster and best rare disease medication Set up medical team of specialty care, contribute the 16 new product launching in the coming years

In charge of Pfizer Upjohn MA Team , including CVM , CNS, Urology and Pain.Synergy all resources ,optimize cross TA advantages and combine digital tools to serve and benefit more patients in proper ways. Dig out more BD opportunities to strong the chronic diseases portfolio based on current and future need.

Responsible for medical affairs of hypertension group , chronic diseases management cooperation with internal and external customers. Innovative pilot and digital platform to trigger the new model of chronic disease management in more and more complicated environment, serve policy shaping and more effective multiple diseases care.

Responsible for medical affairs of hypertension group , chronic diseases management cooperation with internal and external customers.

Lead MA team covering ophthalmology and rare diseases, and support NDA reivewn as key representative and speaker for CDE questionaire panel meeting, get final approval although facing big challenge. Successfully support new product launching and develop key medical strategy and KOL development plan.

Medical Affairs for mature TA-Ophthalmology , and new products of Hemophilia. Meanwhile , taking clinical clinician role of hemophilia Phase III for NDA application.

Medical affairs for Ophthalmology

Responsible for medical affairs of ophthalmology products and new products (anti-VEGF for wet-AMD , DME)